Skip to main content
Aarti Pharmalabs Limited logo

Aarti Pharmalabs Limited — Investor Relations & Filings

Ticker · AARTIPHARM ISIN · INE0LRU01027 LEI · 335800TTAKRBNDK5P363 BSE.NS Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2023-07-28 Regulatory Filings
Country IN India
Listing BSE.NS AARTIPHARM

About Aarti Pharmalabs Limited

https://www.aartipharmalabs.com/

Aarti Pharmalabs Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives. The company specializes in the development and production of complex chemistry-based products for the global pharmaceutical and generic drug industries. Its core portfolio includes APIs across diverse therapeutic areas such as oncology, cardiovascular, and anti-diabetics. Additionally, the company is a major producer of xanthines, including caffeine and theophylline. Aarti Pharmalabs offers comprehensive Contract Development and Manufacturing Organization (CDMO) services, leveraging its integrated research and development capabilities and large-scale manufacturing facilities. The organization maintains high regulatory standards, ensuring compliance with international quality benchmarks to serve a global clientele.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for August 5, 2023. The purpose of the meeting is to consider and approve the audited financial results for the quarter ended June 30, 2023. The letter references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about board meetings. The document does not contain the financial results themselves, only an intimation of the meeting where these results will be approved. The document length is short (1432 characters), and it serves as a notice rather than a report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a board meeting and upcoming financial results, not the financial report itself or a detailed management discussion.
2023-07-28 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a declaration under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It confirms that no encumbrance was made on the shares by promoters or promoter group members during the financial year 2022-2023. The document includes a list of promoters and promoter group members as an annexure. This is a regulatory compliance filing related to shareholding and encumbrance disclosures, not a financial report, earnings release, or management report. It is a formal notification to stock exchanges and regulatory bodies about shareholding status. Therefore, it fits best under Major Shareholding Notification (MRQ) category, which covers notifications of changes or confirmations in significant share ownership levels or related disclosures under takeover regulations.
2023-07-09 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a declaration under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It confirms that no encumbrance was made on shares by promoters or promoter group members during the financial year 2022-2023. The document includes a list of promoters and promoter group members as an annexure. This is a regulatory compliance declaration related to shareholding and encumbrance status, not a financial report, earnings release, or management information. It is a formal notification to stock exchanges and regulatory bodies about shareholding status under SEBI regulations. Therefore, it fits best under Major Shareholding Notification (MRQ) category, which covers notifications of changes or confirmations in significant share ownership or related disclosures under SEBI regulations.
2023-07-09 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, related to shareholding or depository participant compliance for the quarter ended June 30, 2023. It is a short letter addressed to stock exchanges with an enclosed certificate from the registrar and share transfer agent. It does not contain financial statements, management discussion, or detailed financial data. It is primarily a regulatory compliance certificate. According to the rules, such officer certifications or compliance certificates should be classified as Regulatory Filings (RNS). The document length is short (1199 characters), and it is not a report itself but a certificate submission.
2023-07-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the closure of the trading window due to upcoming financial results announcement, referencing SEBI (Prohibition of Insider Trading) Regulations. It is a regulatory compliance announcement related to insider trading restrictions, not a financial report or earnings release itself. The document is short (1336 characters) and serves as a notification rather than containing financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents.
2023-06-29 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Analyst Presentation' and is addressed to stock exchanges referencing Regulation 30(6) of SEBI (LODR) Regulations 2015, which pertains to disclosure of material events. The content includes company overview, key metrics, financial highlights, and business journey details. There is no indication of full financial statements or detailed financial analysis typical of annual or interim reports. The document is a presentation intended for analysts and investors, focusing on company strategy, market position, and financial highlights rather than comprehensive reporting. Therefore, it fits the category of an Investor Presentation (IP). The document length is substantial (15,000 characters), supporting a detailed presentation rather than a brief announcement or certification.
2023-06-26 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.